We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
SELLAS Life Sciences Group Inc | NASDAQ:SLS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.03 | -2.22% | 1.32 | 0.80 | 1.33 | 1.37 | 1.29 | 1.36 | 786,873 | 05:00:11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
001-33958
|
|
20-8099512
|
(State or other jurisdiction of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
|
|
15 West 38th Street, 10th Floor
New York, NY 10018
|
|
|
|
|
(Address of Principal Executive Offices) (Zip Code)
|
|
|
|
|
|
|
|
Registrant’s telephone number, including area code:
(917) 438-4353
|
||||
|
|
|
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.0001 par value per share
|
SLS
|
The Nasdaq Capital Market
|
NAME
|
|
FOR
|
|
WITHHELD
|
|
BROKER NON-VOTES
|
Angelos M. Stergiou
|
|
3,099,811
|
|
1,734,859
|
|
11,144,702
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
2,719,941
|
|
2,062,906
|
|
51,823
|
|
11,144,702
|
EVERY YEAR
|
|
EVERY TWO YEARS
|
|
EVERY THREE YEARS
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
3,104,406
|
|
101,977
|
|
265,208
|
|
1,363,079
|
|
11,144,702
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
12,001,920
|
|
511,121
|
|
3,466,331
|
|
—
|
|
|
|
|
SELLAS Life Sciences Group, Inc.
|
||||
|
|
|
|
|
||||
Date:
|
|
July 15, 2019
|
|
|
|
By:
|
|
/s/ Barbara A. Wood
|
|
|
|
|
|
|
|
Name:
|
Barbara A. Wood
|
|
|
|
|
|
|
|
Title:
|
Executive Vice President, General Counsel
|
1 Year SELLAS Life Sciences Chart |
1 Month SELLAS Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions